Effectiveness of a home-based re-injury prevention program on motor control, return to sport and recurrence rates after anterior cruciate ligament reconstruction: study protocol for a multicenter, single-blind, randomized controlled trial (PReP)

Standard

Effectiveness of a home-based re-injury prevention program on motor control, return to sport and recurrence rates after anterior cruciate ligament reconstruction: study protocol for a multicenter, single-blind, randomized controlled trial (PReP). / Niederer, Daniel; Keller, Matthias; Achtnich, Andrea; Akoto, Ralph; Ateschrang, Atesch; Banzer, Winfried; Barié, Alexander; Best, Raymond; Ellermann, Andree; Fischer, Andreas; Guenther, Daniel; Herbort, Mirco; Höher, Jürgen; Janko, Maren; Jung, Tobias M; Krause, Matthias; Petersen, Wolf; Stoffels, Thomas; Stöhr, Amelie; Welsch, Frederic; Stein, Thomas.

In: TRIALS, Vol. 20, No. 1, 13.08.2019, p. 495.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Niederer, D, Keller, M, Achtnich, A, Akoto, R, Ateschrang, A, Banzer, W, Barié, A, Best, R, Ellermann, A, Fischer, A, Guenther, D, Herbort, M, Höher, J, Janko, M, Jung, TM, Krause, M, Petersen, W, Stoffels, T, Stöhr, A, Welsch, F & Stein, T 2019, 'Effectiveness of a home-based re-injury prevention program on motor control, return to sport and recurrence rates after anterior cruciate ligament reconstruction: study protocol for a multicenter, single-blind, randomized controlled trial (PReP)', TRIALS, vol. 20, no. 1, pp. 495. https://doi.org/10.1186/s13063-019-3610-2

APA

Niederer, D., Keller, M., Achtnich, A., Akoto, R., Ateschrang, A., Banzer, W., Barié, A., Best, R., Ellermann, A., Fischer, A., Guenther, D., Herbort, M., Höher, J., Janko, M., Jung, T. M., Krause, M., Petersen, W., Stoffels, T., Stöhr, A., ... Stein, T. (2019). Effectiveness of a home-based re-injury prevention program on motor control, return to sport and recurrence rates after anterior cruciate ligament reconstruction: study protocol for a multicenter, single-blind, randomized controlled trial (PReP). TRIALS, 20(1), 495. https://doi.org/10.1186/s13063-019-3610-2

Vancouver

Bibtex

@article{0063f816d7c14b47afe27fc9a4206911,
title = "Effectiveness of a home-based re-injury prevention program on motor control, return to sport and recurrence rates after anterior cruciate ligament reconstruction: study protocol for a multicenter, single-blind, randomized controlled trial (PReP)",
abstract = "BACKGROUND: Although anterior cruciate ligament (ACL) tear-prevention programs may be effective in the (secondary) prevention of a subsequent ACL injury, little is known, yet, on their effectiveness and feasibility. This study assesses the effects and implementation capacity of a secondary preventive motor-control training (the Stop-X program) after ACL reconstruction.METHODS AND DESIGN: A multicenter, single-blind, randomized controlled, prospective, superiority, two-arm design is adopted. Subsequent patients (18-35 years) with primary arthroscopic unilateral ACL reconstruction with autologous hamstring graft are enrolled. Postoperative guideline rehabilitation plus Classic follow-up treatment and guideline rehabilitation plus the Stop-X intervention will be compared. The onset of the Stop-X program as part of the postoperative follow-up treatment is individualized and function based. The participants must be released for the training components. The endpoint is the unrestricted return to sport (RTS) decision. Before (where applicable) reconstruction and after the clearance for the intervention (aimed at 4-8 months post surgery) until the unrestricted RTS decision (but at least until 12 months post surgery), all outcomes will be assessed once a month. Each participant is consequently measured at least five times to a maximum of 12 times. Twelve, 18 and 24 months after the surgery, follow-up-measurements and recurrence monitoring will follow. The primary outcome assessement (normalized knee-separation distance at the Drop Jump Screening Test (DJST)) is followed by the functional secondary outcomes assessements. The latter consist of quality assessments during simple (combined) balance side, balance front and single-leg hops for distance. All hop/jump tests are self-administered and filmed from the frontal view (3-m distance). All videos are transferred using safe big content transfer and subsequently (and blinded) expertly video-rated. Secondary outcomes are questionnaires on patient-reported knee function, kinesiophobia, RTS after ACL injury and training/therapy volume (frequency - intensity - type and time). All questionnaires are completed online using the participants' pseudonym only. Group allocation is executed randomly. The training intervention (Stop-X arm) consists of self-administered home-based exercises. The exercises are step-wise graduated and follow wound healing and functional restoration criteria. The training frequency for both arms is scheduled to be three times per week, each time for a 30 min duration. The program follows current (secondary) prevention guidelines. Repeated measurements gain-score analyses using analyses of (co-)variance are performed for all outcomes.TRIAL REGISTRATION: German Clinical Trials Register, identification number DRKS00015313 . Registered on 1 October 2018.",
author = "Daniel Niederer and Matthias Keller and Andrea Achtnich and Ralph Akoto and Atesch Ateschrang and Winfried Banzer and Alexander Bari{\'e} and Raymond Best and Andree Ellermann and Andreas Fischer and Daniel Guenther and Mirco Herbort and J{\"u}rgen H{\"o}her and Maren Janko and Jung, {Tobias M} and Matthias Krause and Wolf Petersen and Thomas Stoffels and Amelie St{\"o}hr and Frederic Welsch and Thomas Stein",
year = "2019",
month = aug,
day = "13",
doi = "10.1186/s13063-019-3610-2",
language = "English",
volume = "20",
pages = "495",
journal = "TRIALS",
issn = "1745-6215",
publisher = "Current Controlled Trials Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Effectiveness of a home-based re-injury prevention program on motor control, return to sport and recurrence rates after anterior cruciate ligament reconstruction: study protocol for a multicenter, single-blind, randomized controlled trial (PReP)

AU - Niederer, Daniel

AU - Keller, Matthias

AU - Achtnich, Andrea

AU - Akoto, Ralph

AU - Ateschrang, Atesch

AU - Banzer, Winfried

AU - Barié, Alexander

AU - Best, Raymond

AU - Ellermann, Andree

AU - Fischer, Andreas

AU - Guenther, Daniel

AU - Herbort, Mirco

AU - Höher, Jürgen

AU - Janko, Maren

AU - Jung, Tobias M

AU - Krause, Matthias

AU - Petersen, Wolf

AU - Stoffels, Thomas

AU - Stöhr, Amelie

AU - Welsch, Frederic

AU - Stein, Thomas

PY - 2019/8/13

Y1 - 2019/8/13

N2 - BACKGROUND: Although anterior cruciate ligament (ACL) tear-prevention programs may be effective in the (secondary) prevention of a subsequent ACL injury, little is known, yet, on their effectiveness and feasibility. This study assesses the effects and implementation capacity of a secondary preventive motor-control training (the Stop-X program) after ACL reconstruction.METHODS AND DESIGN: A multicenter, single-blind, randomized controlled, prospective, superiority, two-arm design is adopted. Subsequent patients (18-35 years) with primary arthroscopic unilateral ACL reconstruction with autologous hamstring graft are enrolled. Postoperative guideline rehabilitation plus Classic follow-up treatment and guideline rehabilitation plus the Stop-X intervention will be compared. The onset of the Stop-X program as part of the postoperative follow-up treatment is individualized and function based. The participants must be released for the training components. The endpoint is the unrestricted return to sport (RTS) decision. Before (where applicable) reconstruction and after the clearance for the intervention (aimed at 4-8 months post surgery) until the unrestricted RTS decision (but at least until 12 months post surgery), all outcomes will be assessed once a month. Each participant is consequently measured at least five times to a maximum of 12 times. Twelve, 18 and 24 months after the surgery, follow-up-measurements and recurrence monitoring will follow. The primary outcome assessement (normalized knee-separation distance at the Drop Jump Screening Test (DJST)) is followed by the functional secondary outcomes assessements. The latter consist of quality assessments during simple (combined) balance side, balance front and single-leg hops for distance. All hop/jump tests are self-administered and filmed from the frontal view (3-m distance). All videos are transferred using safe big content transfer and subsequently (and blinded) expertly video-rated. Secondary outcomes are questionnaires on patient-reported knee function, kinesiophobia, RTS after ACL injury and training/therapy volume (frequency - intensity - type and time). All questionnaires are completed online using the participants' pseudonym only. Group allocation is executed randomly. The training intervention (Stop-X arm) consists of self-administered home-based exercises. The exercises are step-wise graduated and follow wound healing and functional restoration criteria. The training frequency for both arms is scheduled to be three times per week, each time for a 30 min duration. The program follows current (secondary) prevention guidelines. Repeated measurements gain-score analyses using analyses of (co-)variance are performed for all outcomes.TRIAL REGISTRATION: German Clinical Trials Register, identification number DRKS00015313 . Registered on 1 October 2018.

AB - BACKGROUND: Although anterior cruciate ligament (ACL) tear-prevention programs may be effective in the (secondary) prevention of a subsequent ACL injury, little is known, yet, on their effectiveness and feasibility. This study assesses the effects and implementation capacity of a secondary preventive motor-control training (the Stop-X program) after ACL reconstruction.METHODS AND DESIGN: A multicenter, single-blind, randomized controlled, prospective, superiority, two-arm design is adopted. Subsequent patients (18-35 years) with primary arthroscopic unilateral ACL reconstruction with autologous hamstring graft are enrolled. Postoperative guideline rehabilitation plus Classic follow-up treatment and guideline rehabilitation plus the Stop-X intervention will be compared. The onset of the Stop-X program as part of the postoperative follow-up treatment is individualized and function based. The participants must be released for the training components. The endpoint is the unrestricted return to sport (RTS) decision. Before (where applicable) reconstruction and after the clearance for the intervention (aimed at 4-8 months post surgery) until the unrestricted RTS decision (but at least until 12 months post surgery), all outcomes will be assessed once a month. Each participant is consequently measured at least five times to a maximum of 12 times. Twelve, 18 and 24 months after the surgery, follow-up-measurements and recurrence monitoring will follow. The primary outcome assessement (normalized knee-separation distance at the Drop Jump Screening Test (DJST)) is followed by the functional secondary outcomes assessements. The latter consist of quality assessments during simple (combined) balance side, balance front and single-leg hops for distance. All hop/jump tests are self-administered and filmed from the frontal view (3-m distance). All videos are transferred using safe big content transfer and subsequently (and blinded) expertly video-rated. Secondary outcomes are questionnaires on patient-reported knee function, kinesiophobia, RTS after ACL injury and training/therapy volume (frequency - intensity - type and time). All questionnaires are completed online using the participants' pseudonym only. Group allocation is executed randomly. The training intervention (Stop-X arm) consists of self-administered home-based exercises. The exercises are step-wise graduated and follow wound healing and functional restoration criteria. The training frequency for both arms is scheduled to be three times per week, each time for a 30 min duration. The program follows current (secondary) prevention guidelines. Repeated measurements gain-score analyses using analyses of (co-)variance are performed for all outcomes.TRIAL REGISTRATION: German Clinical Trials Register, identification number DRKS00015313 . Registered on 1 October 2018.

U2 - 10.1186/s13063-019-3610-2

DO - 10.1186/s13063-019-3610-2

M3 - SCORING: Journal article

C2 - 31409425

VL - 20

SP - 495

JO - TRIALS

JF - TRIALS

SN - 1745-6215

IS - 1

ER -